structure therapeutics - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

structure therapeutics

Novo Nordisk GLP-1 competition visual with obesity pill and injectable pen contrasted on dark background

Pharma & Healthcare·Stocks·Europe

Novo Nordisk GLP-1 competition Warning with new pill rival

By Maik Kemper • Mar 17, 2026

Novo Nordisk GLP-1 competition visual with obesity pill and injectable pen contrasted on dark background

Pharma & Healthcare·Stocks·Europe

Novo Nordisk GLP-1 competition Warning with new pill rival

By Maik Kemper • Mar 17, 2026

Can Novo Nordisk defend its GLP-1 dominance as a potent oral rival emerges and a bold US telehealth deal reshapes distribution? How does Structure Therapeutics…